We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · March 28, 2021

Recombinant Zoster Vaccine Is Safe and Effective After Allogeneic Hematopoietic Cell Transplantation

Blood advances

 

Additional Info

Blood advances
Safety and Reactogenicity of the Recombinant Zoster Vaccine After Allogeneic Hematopoietic Cell Transplantation
Blood Adv 2021 Mar 23;5(6)1585-1593, E Baumrin, NE Izaguirre, B Bausk, MM Feeley, CP Bay, Q Yang, VT Ho, LR Baden, NC Issa

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading